Xenoscience Inc.

Phoenix, Arizona 85004

We've found

4 trials

at this facility

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Phoenix, AZ

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Phoenix, AZ

Study of BHV-4157 in Alzheimer's Disease

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

Phoenix, AZ

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Phoenix, AZ

Use our guide to learn which trials are right for you!